Page last updated: 2024-08-05 10:56:09
tetramine
Any polyamine that contains four amino groups.
ChEBI ID: 39166
Members (9)
Member | Definition | Role |
---|---|---|
3,7-diazanonane-1,9-diamine | 2,3,2-tetramine | |
methenamine | A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms. | hexamethylenetetramine |
methoctramine | A tetramine that is N,N'-bis(6-aminohexyl)octane-1,8-diamine where the primary amino groups both carry 2-methoxybenzyl substituents. | methoctramine |
n(1), n(12)-diethylspermine | A substituted spermine that is spermine in which a hydrogen attached to each of the primary amino groups has been replaced by an ethyl group. | N(1),N(12)-diethylspermine |
norspermine | A polyazaalkane consisting of a 13-membered straight chain alkane with aza-groups at the 1-, 5-, 9- and 13-positions. | 3,3,3-tetramine |
spermine | A polyazaalkane that is tetradecane in which the carbons at positions 1, 5, 10 and 14 are replaced by nitrogens. Spermine has broad actions on cellular metabolism. | spermine |
thermospermine | Propane-1,3-diamine in which a hydrogen attached to one nitrogen is substituted by a 3-aminoprop-1-yl group, and a hydrogen attached to the other nitrogen is substituted by a 4-aminobut-1-yl group. A polyamine natural product, its name arises from its similarity to spermine and the fact that it was first isolated from the extreme thermophile, Thermus thermophilus. | thermospermine |
trientine | A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens. | 2,2,2-tetramine |
tris(2-aminoethyl)amine | tris(2-aminoethyl)amine |
Research
Studies (7,412)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 2,919 (39.38) | 18.7374 |
1990's | 1,564 (21.10) | 18.2507 |
2000's | 1,419 (19.14) | 29.6817 |
2010's | 1,118 (15.08) | 24.3611 |
2020's | 392 (5.29) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 106 (1.33%) | 5.53% |
Reviews | 304 (3.83%) | 6.00% |
Case Studies | 124 (1.56%) | 4.05% |
Observational | 2 (0.03%) | 0.25% |
Other | 7,411 (93.26%) | 84.16% |